The mode of action of metronidazole in Helicobacter pylori: futile cycling or reduction?

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JAC/41.1.67PMID 9511039
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pyruvate metabolism in Helicobacter pylori

  2004cited by this paper
• Oxygen scavenging, NADH oxidase and metronidazole resistance in Helicobacter pylori.

  1997cited by this paper
• The urea cycle of Helicobacter pylori.

  1996cited by this paper
• Multiple strain colonization and metronidazole resistance in Helicobacter pylori-infected patients: identification from sequential and multiple biopsy specimens.

  1996cited by this paper
• Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs.

  1995cited by this paper
• Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains

  1995cited by this paper
• Identification of carboxylation enzymes and characterization of a novel four-subunit pyruvate:flavodoxin oxidoreductase from Helicobacter pylori

  1995cited by this paper
• The influence of microaerophilia and anaerobiosis on metronidazole uptake in Helicobacter pylori.

  1995cited by this paper
• Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection.

  1995cited by this paper
• Metronidazole uptake in Helicobacter pylori.

  1995cited by this paper
• Metabolism of pyruvate and glucose by intact cells of Helicobacter pylori studied by 13C NMR spectroscopy.

  1994cited by this paper
• Short‐term low‐dose triple therapy for the eradication of Helicobacter pylori

  1994cited by this paper
• Metabolism of pyruvate and glucose by intact cells of Helicobacter pylori studied by 13C NMR spectroscopy.

  1994cited by this paper
• Impact of metronidazole resistance on the eradication of Helicobacter pylori.

  1994cited by this paper
• Pathogenicity of Helicobacter pylori: a perspective

  1993cited by this paper
• Metronidazole uptake by sensitive and resistant isolates of Helicobacter pylori.

  1993cited by this paper
• Nitroimidazole drugs--action and resistance mechanisms. I. Mechanisms of action.

  1993cited by this paper
• Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori.

  1993cited by this paper
• Role of metronidazole resistance in therapy of Helicobacter pylori infections

  1992cited by this paper
• DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting.

  1992cited by this paper
• Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori.

  1992cited by this paper
• Catalase negative mutants ofHelicobacter pylori

  1992cited by this paper
• Proposed mechanism for metronidazole resistance in Helicobacter pylori.

  1992cited by this paper
• Factors influencing the eradication of Helicobacter pylori with triple therapy.

  1992cited by this paper
• Experience with‘triple’ anti‐Helicobacter pylori eradication therapy: side effects and the importance of testing the pre‐treatment bacterial isolate for metronidazole resistance

  1992cited by this paper
• Helicobacter pylori catalase.

  1991cited by this paper
• Effect of metronidazole on surface properties of Bacteroides fragilis.

  1991cited by this paper
• Drug therapy for Helicobacter pylori infection: problems and pitfalls.

  1990cited by this paper
• Ferredoxin-dependent reduction of nitroimidazole derivatives in drug-resistant and susceptible strains of Trichomonas vaginalis.

  1986cited by this paper
• Reduction of nitroimidazoles in vitro and DNA damage.

  1986cited by this paper
• Reductive activation of nitroimidazoles in anaerobic microorganisms.

  1986cited by this paper
• Reductions in organic chemistry

  1984cited by this paper
• The reductive metabolism of metronidazole and ronidazole by aerobic liver microsomes.

  1980cited by this paper
• Inactivation of metronidazole by aerobic organisms.

  1979cited by this paper
• The interaction of reduced metronidazole with DNA.

  1978cited by this paper
• Incomplete anaerobiosis as a cause of metronidazole 'resistance'.

  1978cited by this paper
• Superoxide dismutase: "positive" spectrophotometric assays.

  1977cited by this paper
• Interaction of metronidazole with nucleic acids in vitro.

  1977cited by this paper
• Uptake of Metronidazole and Its Effect on Viability in Trichomonads and Entamoeba invadens Under Anaerobic and Aerobic Conditions

  1976cited by this paper
• The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms.

  1974cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Biomarker Characterization and Prediction of Virulence and Antibiotic Resistance from Helicobacter pylori Next Generation Sequencing Data

  2022cites this paper
• Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.

  2020cites this paper
• Practical and Metal-Free Synthesis of Novel Enantiopure Amides Containing the Potentially Bioactive 5-Nitroimidazole Moiety

  2016cites this paper
• Synthesis and Characterization of Gold Nanoparticles using 2-(2-methyl-5-amino -1H-imidazol-1-yl) ethanol

  2015cites this paper
• Synthesis and biological evaluation of novel N-substituted 1H-dibenzo[a,c]carbazole derivatives of dehydroabietic acid as potential antimicrobial agents.

  2014cites this paper
• First single electron transfer reaction on propargylic chloride in 5-nitroimidazole series

  2014cites this paper
• Designing New 5‐Nitroimidazoles: Towards Safer Anti‐infectious Agents

  2014cites this paper
• Next Generation 5-Nitroimidazole Compounds Show Potential as New Therapeutic Alternatives to Metronidazole in Helicobacter pylori Infection

  2013cites this paper
• Long distance-SRN1 in nitroimidazole series favored by temperature

  2011cites this paper
• In Vitro Anti-Helicobacter pylori Activity of Chinese Chive (Allium tuberosum)

  2011cites this paper
• High Functionalization of 5-Nitro-1H-imidazole Derivatives: The TDAE Approach

  2011cites this paper
• Antimicrobial activity of aminoreductone against Helicobacter pylori.

  2009cites this paper
• In Vitro Antibacterial Activity of Acyl-Lysyl Oligomers against Helicobacter pylori

  2009cites this paper
• Detection of the drug-resistant gene of Helicobacter pylori

  2008cites this paper
• Who's Winning the War? Molecular Mechanisms of Antibiotic Resistance in Helicobacter pylori.

  2008cites this paper
• Characterization of (R)-2-Hydroxyisocaproate Dehydrogenase and a Family III Coenzyme A Transferase Involved in Reduction of l-Leucine to Isocaproate by Clostridium difficile

  2006cites this paper
• In vitro induction of resistance to metronidazole, and analysis of mutations in rdxA and frxA genes from Helicobacter pylori isolates

  2005cites this paper
• Evidence of self-protonation on the electrodic reduction mechanism of an anti-Helicobacter pylori metronidazole isotere

  2004cites this paper
• Effect of metronidazole on hydrogen production by Clostridium acetobutylicum

  2004cites this paper
• Characterization of the genes rdxA and frxA involved in metronidazole resistance in Helicobacter pylori.

  2003cites this paper
• Is the molecular basis of metronidazole resistance in microaerophilic organisms understood?

  2002cites this paper
• Metronidazole resistance in Helicobacter pylori.

  2002cites this paper
• Review Helicobacter pylori susceptibility testing by disc diffusion

  2002cites this paper
• Helicobacter pylori susceptibility testing by disc diffusion.

  2002cites this paper
• Genome-Scale Metabolic Model of Helicobacter pylori 26695

  2002cites this paper
• Resistance of Helicobacter pylori to antibiotics and its impact on treatment options.

  2001cites this paper
• Intracellular redox status and antibiotic resistance in enterogastric micro-aerophilic bacteria: evidence for the ‘scavenging of oxygen’ hypothesis

  2001cites this paper
• Antibiotic susceptibility and resistance

  2001cites this paper
• Mechanism and Clinical Significance of Metronidazole Resistance in Helicobacter pylori

  2001cites this paper
• p-Hydroxyphenylacetate decarboxylase from Clostridium difficile. A novel glycyl radical enzyme catalysing the formation of p-cresol.

  2001cites this paper
• Antibiotic resistance of Helicobacter pylori

  2001cites this paper
• Potential involvement of several nitroreductases in metronidazole resistance in Helicobacter pylori.

  2001cites this paper
• Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori.

  2001cites this paper
• Use of digoxigenin-labelled ampicillin in the identification of penicillin-binding proteins in Helicobacter pylori.

  2000cites this paper
• Analysis of rdxA and Involvement of Additional Genes Encoding NAD(P)H Flavin Oxidoreductase (FrxA) and Ferredoxin-Like Protein (FdxB) in Metronidazole Resistance of Helicobacter pylori

  2000cites this paper
• Sequential Inactivation of rdxA (HP0954) and frxA (HP0642) Nitroreductase Genes Causes Moderate and High-Level Metronidazole Resistance in Helicobacter pylori

  2000cites this paper
• Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States.

  1999cites this paper
• Will Helicobacter pylori be the Next Organism for Which We Will Have Exhausted Our Treatment Options?

  1999cites this paper
• Metronidazole resistance and microaerophily in Campylobacter species

  1998cites this paper
• Antibacterials - mechanisms of action.

  1998cites this paper
• A practical approach to the diagnosis and therapy of helicobacter pylori infection

  1997cites this paper